Search
Search Results
##search.searchResults.foundPlural##
-
ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.
1164PDF: 697HTML: 281 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
1846PDF: 762HTML: 204 -
HIV INFECTION, ANTIRETROVIRAL THERAPY AND CARDIOVASCULAR RISK
1754PDF: 773HTML: 3580 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3750PDF: 1401HTML: 8481 -
HEPARIN-BINDING PROTEIN AS A DIAGNOSTIC AND PROGNOSTIC MARKER OF INFECTIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS Heparin-binding protein in adult patients
1940PDF: 878HTML: 122Suppl. Files: 488 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
1855PDF: 1320HTML: 244 -
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
976PDF: 930HTML: 297 -
EVALUATION OF THE PLASMA MICRO RNA EXPRESSION LEVELS IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
1319PDF: 654HTML: 1063Untitled: 162Untitled: 128Untitled: 112Untitled: 131Untitled: 139 -
FAMILIAL MEDITERRANEAN FEVER AND HYPERCOAGULABILITY
1137PDF: 683HTML: 1200 -
PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.
2002PDF: 998HTML: 15639COVER LETTER: 163 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
374PDF: 195HTML: 69 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4100PDF: 1484HTML: 419 -
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
652PDF: 778PDF Supp. Files: 67HTML: 169 -
DISTRIBUTION OF DNA DAMAGE REPAIR GENE POLYMORPHISM hOGG1, XRCC1 and p53 AMONG SICKLE CELL DISEASE PATIENTS IN INDIA
1444PDF: 753HTML: 1458Table Genotype and allele frequencies of hOGG1 codon 326 Ser>Cys and p53 72Arg>Pro polymorphisms among SCD patients and control group: 159 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3292PDF: 1245HTML: 1843Fig.1: 177Fig. 2: 184 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
699PDF: 450HTML: 6243
1 - 35 of 35 items







